Investigate Safety, Tolerability, PK/PK of J2H 1702 in Healthy Males

Summary

1. Research Purpose: To evaluate the safety, tolerability, pharmacokinetic/pharmacodynamic properties of J2H-1702 (a candidate for treatment of non-alcoholic steatohepatitis) in healthy men. 2. Design: A dose block-randomized, double-blind, placebo controlled, single- and multiple dosing, dose-escalation phase 1 clinical trial

Timeline

Start

2020-08-12

Primary completion

2021-06-25

Completion

2021-07-13

Drugs

Indications